insights_auto
Why is SOBI up 2.15%?
Dive Deeperchevron_right
SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEKÂ 446.60
arrow_upward
+2.15%(+9.40) 1D
Oct 20, 5:29:52 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEKÂ 440.00
High
SEKÂ 447.80
Low
SEKÂ 437.40
Mkt. cap
159.72B
Avg. vol.
259.17K
Volume
328.11K
P/E ratio
119.28
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 304.80
EPS
SEKÂ 3.74
Shares outstanding
357.64M
No. of employees
2K
Open
SEKÂ 440.00
High
SEKÂ 447.80
Low
SEKÂ 437.40
Mkt. cap
159.72B
Avg. vol.
259.17K
Volume
328.11K
P/E ratio
119.28
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 304.80
EPS
SEKÂ 3.74
Shares outstanding
357.64M
No. of employees
2K
News stories
From web sources and news partners
ChartMill
·
1 hour ago
Most Active S&P 500 Stocks in Today's Session
FXEmpire
·
35 minutes ago
Dow Jones Price Forecast: Bulls Eye 57,000 as October 6 Low Remains Key
Insider Monkey
·
2 hours ago
Ciena (CIEN): Is the AI-Optical Boom Enough to Carry It Into the S&P 500?
Yahoo Finance
·
2 hours ago
United Therapeutics (UTHR): Can the Profit-Machine Biotech Finally Crack the S&P 500?
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)